Status:
COMPLETED
Seizure Prophylaxis in Aneurysm Repair
Lead Sponsor:
University of Michigan
Conditions:
Intracranial Aneurysms
Seizure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
After a thorough review of the existing literature as well as a review of our own practice, the investigators have concluded that the decision to treat patients undergoing aneurysm repair with levetir...
Eligibility Criteria
Inclusion
- Adult (≥18 years)
- Presence of intracranial aneurysm (with or without rupture)
- Treating surgeon has recommended surgical repair of the aneurysm
Exclusion
- History of seizures within last 10 years
- History of epilepsy
- History of prior stroke
- Currently prescribed medication with anti-epileptic activity (keppra, dilantin, tegretol, lamictal, topamax, etc.)
- Brain tumor
- Pregnant or nursing woman
- Known levetiracetam allergy
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 6 2023
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT01801072
Start Date
February 1 2013
End Date
October 6 2023
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109